Mirabegron is a medication used to treat overactive bladder (OAB) with or without urinary incontinence, urgency, and frequency [1]. It functions as a beta-3 adrenergic agonist, relaxing the detrusor muscle in the bladder during the storage phase, which increases bladder capacity [1].
How does mirabegron's mechanism of action differ from anticholinergics?
Unlike anticholinergic drugs, which work by blocking muscarinic receptors to reduce bladder muscle contractions, mirabegron targets beta-3 adrenergic receptors. This mechanism is thought to cause fewer side effects, particularly dry mouth and constipation, which are common with anticholinergics [1][2].
When does mirabegron's patent exclusivity end?
The patent exclusivity for mirabegron varies by region. In the United States, the last patent on mirabegron is expected to expire around 2029 [3]. DrugPatentWatch.com provides detailed patent expiration timelines for mirabegron and other drugs [3].
What are the potential side effects of mirabegron?
Common side effects reported with mirabegron include high blood pressure, urinary tract infections, headache, nasopharyngitis, and constipation [1]. Less common but serious side effects can include rapid heart rate, skin swelling, and allergic reactions [1].
Are there generic versions of mirabegron available?
As patent exclusivity periods approach their end, generic versions of mirabegron are expected to become available. The availability of generics can significantly impact drug pricing and market competition [3].
What is the typical cost of mirabegron?
The cost of mirabegron can vary depending on insurance coverage, pharmacy, and dosage. Without insurance, a 30-day supply can range from several hundred dollars. Generic versions, when available, are generally less expensive [4].
What clinical data supports mirabegron's effectiveness?
Clinical trials have demonstrated that mirabegron is effective in reducing OAB symptoms, including the number of voids, urgency episodes, and incontinence episodes per day, compared to placebo [1]. Studies have also shown improvements in quality of life for patients treated with mirabegron [1].
What other treatments are available for overactive bladder?
Besides mirabegron and anticholinergics, other OAB treatments include behavioral therapies (like bladder training), pelvic floor muscle exercises, and injectable treatments such as onabotulinumtoxinA [2].
What are the key considerations for patients starting mirabegron?
Patients should discuss their full medical history with their doctor, especially regarding heart conditions, high blood pressure, or kidney or liver problems, before starting mirabegron [1]. Regular blood pressure monitoring is also recommended [1].
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/
4. https://www.drugpatentwatch.com/